Advances in Peptide Development Current priorities include developing synthetic analogs with longer stability, designing controlled-release systems, and improving delivery methods such as transdermal patches, nasal sprays, or nanoparticle carriers
20% OFF All Products
Hypersensitivity reactions include anaphylaxis, angioedema, rash, urticaria, cutaneous vasculitis, and exfoliative skin conditions including Stevens-Johnson syndrome [see Warnings and Precautions]
Because multiple peptides are involved, it becomes more difficult to attribute observed effects to any one component
Jump to: GLP-1s for type 2 diabetes | GLP-1s for weight loss | Side effects and safety | Take home message GLP-1 receptor agonists (GLP-1s) are a class of medications approved for individuals living with type 2 diabetes and obesity to help lower blood glucose levels (blood sugar) and support weight loss